DMS Imaging (LTS:0RGO) Net Change in Cash : €-0.04 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is DMS Imaging Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

DMS Imaging's Net Change in Cash for the six months ended in Dec. 2023 was €0.77 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.04 Mil.

DMS Imaging Net Change in Cash Historical Data

The historical data trend for DMS Imaging's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DMS Imaging Net Change in Cash Chart

DMS Imaging Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-4.81

-0.80

1.01

1.81

-0.04

DMS Imaging Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Change in Cash	Get a 7-Day Free Trial															1.17	1.31	0.50	-0.81	0.77

DMS Imaging Net Change in Cash Calculation

DMS Imaging's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-2.274	+	-1.507	+	3.742	+	0
	=	-0.04

DMS Imaging's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.295 + -0.159 + 1.221 + 0

= 0.77

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DMS Imaging Net Change in Cash Related Terms
Thank you for viewing the detailed overview of DMS Imaging's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

DMS Imaging (LTS:0RGO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DMS Imaging SA (LTS:0RGO) » Definitions » Net Change in Cash

Comparable Companies

XBRU:CYAD XBRU:BIOS XBRU:OXUR XBRU:ONWD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN

Traded in Other Exchanges

AS0:Germany ALIMG:Belgium

Address

7 Rue des Chasseurs Ardennais, Liege, BEL, 4031

Website

https://www.dms-imaging.com

DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

DMS Imaging (LTS:0RGO) Headlines

No Headlines